Royal Bank of Canada »

Caris Life Sciences shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $129k 4.3k 30.00
2025-06-30 $22k 821 26.80

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
Silver Lake Group
Neuberger Berman Group
Millennium Management
PointState Capital
OrbiMed Advisors
Ameriprise Financial
ClearBridge Advisors
Canada Pension Plan Investment Board
Alliancebernstein
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences